Highest-materiality recent filing
Quanex Q2 net income falls 83% to $3.4M; adjusted EBITDA down 30% YoY
Net sales $462.4M (+2.2% YoY); gross margin 25.5% vs 29.0% a year ago.
Quanex Q1 net loss narrows to $4.1M; FY2026 EBITDA guidance $240-245M
Net sales $409.1M (+2.3% YoY); adjusted diluted EPS ($0.01) vs $0.19 prior year.
Quanex reports Q4 GAAP EPS $0.43; adjusted EPS $0.83; FY net loss $250.8M on goodwill impairment
Q4 net sales $489.8M (-0.5% YoY); FY net sales $1.84B (+43.8% on Tyman acquisition).
Quanex Building Products Reports Q3 2025 Net Loss of $276M, Repays $51.25M Debt, Updates Guidance
Net sales increased 76.7% to $495.3M in Q3 2025 from $280.3M in prior year, driven by Tyman acquisition.
Quanex Q2 net sales rise 70% to $452.5M; Tyman synergy target raised to $45M
Net sales $452.5M (+70% YoY), net income $20.5M, diluted EPS $0.44.
Quanex Q1 fiscal 2025 net loss $14.9M, reaffirms FY2025 sales guidance $1.84-1.86B
Net sales $400.0M, up 67.3% YoY due to Tyman acquisition; organic sales down 6.2% ex-Tyman.
Quanex reports Q4 net loss of $13.9M on Tyman acquisition integration; adj EPS $0.61 vs $0.95 YoY
Net sales $492.2M, +66.6% YoY; Tyman contributed $203.4M in Q4.
Quanex completes Tyman acquisition; pro forma combined revenue $1.39B for nine months
Total consideration $951.7M: $501.7M cash + 14.1M shares valued at $450M at close.
Quanex Q3 net sales $280M, down 6.4% YoY; closes Tyman acquisition, updates FY guidance
Q3 net sales $280.3M (-6.4% YoY); diluted EPS $0.77 vs $0.96; adjusted EPS $0.73 vs $0.97.
Quanex closes acquisition of Tyman for ~$504M cash and 14.1M shares
Aggregate consideration: 14,139,477 new Quanex shares and $504.1M cash (£392.2M at 1.2855).
Quanex and Tyman shareholders approve acquisition; closing expected August 2024
Shareholders of both Quanex (NX) and Tyman (TYMN) voted to approve Quanex's acquisition of Tyman.
Quanex adds 15p special dividend to Tyman offer; secures undertakings for 26.73% of shares
Revised consideration includes Special Dividend of 15 pence per Tyman share, conditional on court sanction.
Quanex amends proxy for Tyman deal, discloses updated projections, synergies and lawsuits
Stockholder lawsuits filed in NY state court allege proxy omitted material financial information; company denies merit but amends to avoid delays.
Quanex amends credit agreement to add $500M term loan and $475M revolver for Tyman acquisition
Amended credit agreement increases revolving credit facility to $475M and adds a $500M term loan A facility.
UK CMA responded to briefing paper with no further questions on the Tyman acquisition.
Quanex Q2 net sales $266.2M (-2.7% YoY); diluted EPS $0.46 vs $0.65; reaffirms FY guidance
Net sales $266.2M, down 2.7% YoY; net income $15.4M ($0.46 diluted EPS) vs $21.5M ($0.65) YoY.
Quanex to acquire Tyman for ~$1.1B enterprise value; offers cash+stock or all-share alternative
Each Tyman share valued at 400p (240p cash + 0.05715 NX shares per share, or 0.14288 all-share capped at 25% of Tyman).
Quanex Q1 revenue down 8.7% to $239.2M; guides FY2024 Adj. EBITDA $145-150M
Diluted EPS $0.19 vs $0.06; adjusted diluted EPS $0.18 vs $0.18 year-over-year.
Quanex reports fiscal Q4 adjusted EPS $0.95 vs $0.75 YoY; revenue down 3.9% to $295.5M
Q4 net sales $295.5M (-3.9% YoY); full-year net sales $1.13B (-7.4% YoY).
Quanex declares $0.08 dividend; CEO Wilson to become Chairman Feb 27, 2024
Quarterly cash dividend of $0.08 per share declared, payable Dec 29, 2023 to holders of record Dec 19, 2023.
Quanex reports record Q3 earnings; raises FY Adjusted EBITDA guidance to $150-155M
Q3 net sales $299.6M (-7.5% YoY); gross margin expanded to 26.2% from 22.4%.
Quanex Q2 net sales $273.5M (-15.3% YoY); reaffirms FY 2023 guidance
Net sales of $273.5M vs $322.9M YoY; diluted EPS $0.65 vs $0.80; adjusted diluted EPS $0.66 vs $0.80.
Quanex Q1 revenue down 2% to $261.9M; net income drops 83%; guides FY Adj. EBITDA $130-142M
Net sales $261.9M (-1.9% YoY); net income $1.9M ($0.06 EPS) vs $11.2M ($0.34) YoY.
Quanex reports record FY2022 revenue of $1.22B, EPS $2.66; repays $25M debt
Q4 net sales $307.5M (+5.4% YoY); FY net sales $1.22B (+13.9% YoY).
On August 12, 2024, the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Manish H. Shah, age 60, and Amit Singhi, age 59, to the Board, effective August 12, 2024.
On August 12, 2024, the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Manish H. Shah, age 60, and Amit Singhi, age 59, to the Board, effective August 12, 2024.
On October 21, 2023, Meredith W. Mendes resigned as a member of the Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”).
On May 15, 2023, Karen Ettredge was named the Company’s Vice President and Corporate Controller and will serve as the Company’s principal accounting officer.
On May 15, 2023, Mark Livingston, Vice-President, Chief Accounting Officer and Controller of Quanex Building Products Corporation (the “Company”), resigned from his position to pursue other interests, effective immediately.
On February 21, 2022, William Griffiths retired as the Executive Chairman of the Board of Directors (the “Board”) Quanex Building Products Corporation (the “Company”). Mr. Griffiths will remain the Company’s Non-Executive Chairman.
The Board of Directors (the “Board”) of Quanex Building Products Corporation (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, appointed Jason Lippert, age 49, to the Board, effective November 1, 2021.
On November 1, 2021, the Company’s current Executive Chairman, William Griffiths, age 70, notified the Board of his intention to retire from the Company as an executive on February 21, 2022. Mr. Griffiths intends to remain as the Company’s Non-Executive Chairman after that time.
Joseph Rupp, age 71, notified the Board of his intention to not stand for re-election at the Company’s next annual meeting of shareholders.
Max materiality 0.90 · Median 0.50 · Most common event earnings